Literature DB >> 15623689

Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures.

A B Ragin1, P Storey, B A Cohen, R R Edelman, L G Epstein.   

Abstract

OBJECTIVE: To study whole-brain MR measures derived from diffusion tensor imaging and magnetization transfer imaging (MTI) for the in vivo assessment of cumulative neuropathologic changes in HIV and to evaluate the quantitative imaging strategies with respect to cognitive status measures including the severity of dementia and the degree of impairment in specific cognitive domains including attention, memory, constructional abilities, and motor speed.
METHODS: Quantitative whole-brain measurements, including fractional anisotropy (FA), apparent diffusion coefficient (ADC), and magnetization transfer ratio (MTR), were derived from histograms and compared in HIV and control participants. Relationships between the MR and cognitive status measures were examined.
RESULTS: Whole-brain FA and MTR were reduced in patients with HIV and correlated with dementia severity. Whole-brain MTR and ADC were correlated with psychomotor deficits. Evaluation of relationships between the studied MR measures indicated a correlation between ADC and MTR; FA was not correlated with either ADC or MTR.
CONCLUSIONS: Findings from this investigation support the use of quantitative whole-brain MR measures for evaluation of disease burden in HIV. Reductions in whole-brain fractional anisotropy and magnetization transfer ratio (MTR) distinguished HIV and control subjects, and these measures were associated with dementia severity. Relationships were identified between whole-brain MTR and apparent diffusion coefficient and psychomotor deficits. Combining these quantitative strategies in neuroimaging examinations may provide more comprehensive information concerning ongoing changes in the brains of HIV patients.

Entities:  

Mesh:

Year:  2004        PMID: 15623689      PMCID: PMC3462070          DOI: 10.1212/01.wnl.0000147477.44791.bd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

1.  Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities.

Authors:  B Giometto; S F An; M Groves; T Scaravilli; J F Geddes; R Miller; B Tavolato; A A Beckett; F Scaravilli
Journal:  Ann Neurol       Date:  1997-07       Impact factor: 10.422

2.  Whole brain diffusion tensor imaging in HIV-associated cognitive impairment.

Authors:  Ann B Ragin; Pippa Storey; Bruce A Cohen; Leon G Epstein; Robert R Edelman
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

3.  Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity.

Authors:  F Raja; F E Sherriff; C S Morris; L R Bridges; M M Esiri
Journal:  Acta Neuropathol       Date:  1997-02       Impact factor: 17.088

Review 4.  Magnetization transfer imaging in AIDS-related brain diseases.

Authors:  V Dousset; J P Armand; P Huot; B Viaud; J M Caille
Journal:  Neuroimaging Clin N Am       Date:  1997-08       Impact factor: 2.264

5.  Correlation of MRI and neuropathology in AIDS.

Authors:  I P Everall; W K Chong; I D Wilkinson; M N Paley; R J Chinn; M A Hall-Craggs; F Scaravilli; P L Lantos; P J Luthert; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 6.  The AIDS dementia complex.

Authors:  R W Price; B J Brew
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

7.  Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS.

Authors:  S F An; B Giometto; M Groves; R F Miller; A A Beckett; F Gray; B Tavolato; F Scaravilli
Journal:  J Neuropathol Exp Neurol       Date:  1997-11       Impact factor: 3.685

8.  Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death.

Authors:  N C Sacktor; H Bacellar; D R Hoover; T E Nance-Sproson; O A Selnes; E N Miller; G J Dal Pan; C Kleeberger; A Brown; A Saah; J C McArthur
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

9.  Whole-brain N-acetylaspartate level and cognitive performance in HIV infection.

Authors:  Sohil H Patel; Matilde Inglese; Guila Glosser; Dennis L Kolson; Robert I Grossman; Oded Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

10.  High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.

Authors:  J P Mottershead; K Schmierer; M Clemence; J S Thornton; F Scaravilli; G J Barker; P S Tofts; J Newcombe; M L Cuzner; R J Ordidge; W I McDonald; D H Miller
Journal:  J Neurol       Date:  2003-11       Impact factor: 4.849

View more
  24 in total

Review 1.  The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors:  David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Monocyte chemoattractant protein-1 correlates with subcortical brain injury in HIV infection.

Authors:  A B Ragin; Y Wu; P Storey; B A Cohen; R R Edelman; L G Epstein
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

3.  Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women.

Authors:  Yamil Gerena; Richard L Skolasky; Joyce M Velez; Dianedis Toro-Nieves; Raul Mayo; Avindra Nath; Valerie Wojna
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

4.  Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients.

Authors:  David F Tate; Jared Conley; Robert H Paul; Kathryn Coop; Song Zhang; Wenjin Zhou; David H Laidlaw; Lynn E Taylor; Timothy Flanigan; Bradford Navia; Ronald Cohen; Karen Tashima
Journal:  Brain Imaging Behav       Date:  2010-01-19       Impact factor: 3.978

5.  Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation.

Authors:  E E O'Connor; A Jaillard; F Renard; T A Zeffiro
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-08       Impact factor: 3.825

6.  Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.

Authors:  Diana Morales; Summer F Acevedo; Richard L Skolasky; Rosa Hechavarria; Sharon Santiago; Tania De La Torre; Elizabeth Maldonado; Valerie Wojna
Journal:  J Neurovirol       Date:  2012-09-13       Impact factor: 2.643

Review 7.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

8.  Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.

Authors:  Michael T Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E Lovell; Arena A Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P Dash; Ying Wu; Jesse Alt; Ajit G Thomas; Rana Rais; Atsushi Kamiya; David J Volsky; Barbara S Slusher
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

9.  Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection.

Authors:  Ann B Ragin; Ying Wu; Renee Ochs; Rachel Scheidegger; Bruce A Cohen; Justin C McArthur; Leon G Epstein; Katherine Conant
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

10.  Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study.

Authors:  Aaron McMurtray; Beau Nakamoto; Cecelia Shikuma; Victor Valcour
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jul-Aug       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.